Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: ALTERITY THERAPEUTICS LIMITED
CIK: 1131343
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2018-08-31
Last Filing Date: 2024-09-26
SEC Filings
Start End Frame Filed ACCN Value View
2017-07-01 2018-06-30 CY2016 2018-08-31 0001144204-18-047425 $ 533,891,470 View
2018-07-01 2019-06-30 CY2017 2019-08-30 0001213900-19-016984 $ 615,772,236 View
2020-07-01 2021-06-30 CY2021 2022-08-31 0001213900-22-052529 $ 147,101,619 View
2022-07-01 2023-06-30 CY2023 2023-08-31 0001213900-23-072629 $ 16,184 View
2023-07-01 2024-01-08 CY2023Q4I 2024-09-26 0001213900-24-082281 $ 0 View
2020-07-01 2021-06-30 CY2021Q2I 2021-09-02 0001213900-21-046254 $ 4,126,364 View
2019-07-01 2020-06-30 CY2020 2020-09-15 0001213900-20-026557 $ 122,729 View
2020-07-01 2020-12-31 CY2020Q4I 2021-02-25 0001213900-21-011474 $ 8,561,862 View
2021-07-01 2021-12-31 CY2021Q4I 2022-02-28 0001213900-22-009569 $ 2,133,452 View
SEC Facts By Type
Type Name Description View
us-gaap Research and Development Expense, Software (Excluding Acquired in Process Cost) Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
ifrs-full 4037932 None View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Receivable and Other Assets Amount of interest receivable and assets classified as other. View
us-gaap Other Income Amount of revenue and income classified as other. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Accrued Income Taxes Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Other Noncash Income Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other. View
us-gaap Other Receivables Amount due from parties in nontrade transactions, classified as other. View
Chart of Accounts => Accounts
Name View
Interest Expense View
Interest Receivable and Other Assets View
Other Income View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Accrued Income Taxes View
General and Administrative Expense View
Other Noncash Income View
Other Receivables View
Research and Development Expense, Software (Excluding Acquired in Process Cost) View